Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 51, Issue 22, Pages 7049-7052Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm801050k
Keywords
-
Categories
Ask authors/readers for more resources
A series of arylaminobenzimidazoles was designed and synthesized as Raf kinase inhibitors. Exploration of the structure-activity relationship resulted in compounds that are potent in vitro and show desirable in vivo properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
